These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24565181)

  • 1. Detection of type 2 diabetes related modules and genes based on epigenetic networks.
    Liu H; Wang T; Liu H; Wei Y; Zhao G; Su J; Wu Q; Qiao H; Zhang Y
    BMC Syst Biol; 2014; 8 Suppl 1(Suppl 1):S5. PubMed ID: 24565181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type 2 diabetes and obesity induce similar transcriptional reprogramming in human myocytes.
    Väremo L; Henriksen TI; Scheele C; Broholm C; Pedersen M; Uhlén M; Pedersen BK; Nielsen J
    Genome Med; 2017 May; 9(1):47. PubMed ID: 28545587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common Genetic Aberrations Associated with Metabolic Interferences in Human Type-2 Diabetes and Acute Myeloid Leukemia: A Bioinformatics Approach.
    Kyriakou TC; Papageorgis P; Christodoulou MI
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA methylation in the pathogenesis of type 2 diabetes.
    Kaimala S; Ansari SA; Emerald BS
    Vitam Horm; 2023; 122():147-169. PubMed ID: 36863792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigenetics in Obesity and Diabetes Mellitus: New Insights.
    Suárez R; Chapela SP; Álvarez-Córdova L; Bautista-Valarezo E; Sarmiento-Andrade Y; Verde L; Frias-Toral E; Sarno G
    Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adipose Tissue Epigenetic Profile in Obesity-Related Dysglycemia - A Systematic Review.
    Andrade S; Morais T; Sandovici I; Seabra AL; Constância M; Monteiro MP
    Front Endocrinol (Lausanne); 2021; 12():681649. PubMed ID: 34290669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation and gene expression analysis in adipose tissue to identify new loci associated with T2D development in obesity.
    Baca P; Barajas-Olmos F; Mirzaeicheshmeh E; Zerrweck C; Guilbert L; Sánchez EC; Flores-Huacuja M; Villafán R; Martínez-Hernández A; García-Ortiz H; Contreras-Cubas C; Centeno-Cruz F; Orozco L
    Nutr Diabetes; 2022 Dec; 12(1):50. PubMed ID: 36535927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Subgroups of Type 2 Diabetes Display Different Epigenetic Patterns That Associate With Future Diabetic Complications.
    Schrader S; Perfilyev A; Ahlqvist E; Groop L; Vaag A; Martinell M; García-Calzón S; Ling C
    Diabetes Care; 2022 Jul; 45(7):1621-1630. PubMed ID: 35607770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Additive and Interactive Genetically Contextual Effects of HbA1c on cg19693031 Methylation in Type 2 Diabetes.
    Dawes K; Philibert W; Darbro B; Simons RL; Philibert R
    Genes (Basel); 2022 Apr; 13(4):. PubMed ID: 35456489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA Methylation and Type 2 Diabetes: Novel Biomarkers for Risk Assessment?
    Raciti GA; Desiderio A; Longo M; Leone A; Zatterale F; Prevenzano I; Miele C; Napoli R; Beguinot F
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative system biology and mathematical modeling of genetic networks identifies shared biomarkers for obesity and diabetes.
    Bima AIH; Elsamanoudy AZ; Albaqami WF; Khan Z; Parambath SV; Al-Rayes N; Kaipa PR; Elango R; Banaganapalli B; Shaik NA
    Math Biosci Eng; 2022 Jan; 19(3):2310-2329. PubMed ID: 35240786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Recent Update on the Epigenetic Repertoire and Chromatin Modifying Therapy in Diabetes Mellitus: A Comprehensive Review.
    Wang X; Zhao D; Beeraka NM; Tatineni S; Sri CD; Nishanth VV; Uthiah CA; Leihang Z; Sugur K; Liu J; Nikolenko VN; Fan R
    Curr Med Chem; 2023; 30(18):2020-2038. PubMed ID: 35927905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin-mediated epigenetic modifications in diabetes and associated conditions: Biological and clinical relevance.
    Giordo R; Posadino AM; Mangoni AA; Pintus G
    Biochem Pharmacol; 2023 Sep; 215():115732. PubMed ID: 37541452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetics of metabolic syndrome.
    Carson C; Lawson HA
    Physiol Genomics; 2018 Nov; 50(11):947-955. PubMed ID: 30240346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic disturbances in obesity and diabetes: Epidemiological and functional insights.
    Loh M; Zhou L; Ng HK; Chambers JC
    Mol Metab; 2019 Sep; 27S(Suppl):S33-S41. PubMed ID: 31500829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic insights into glucose induced vascular epigenetic reprogramming in type 2 diabetes.
    Dhawan P; Vasishta S; Balakrishnan A; Joshi MB
    Life Sci; 2022 Jun; 298():120490. PubMed ID: 35331720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetics of methylation modifications in diabetic cardiomyopathy.
    Hao J; Liu Y
    Front Endocrinol (Lausanne); 2023; 14():1119765. PubMed ID: 37008904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extrinsic and intrinsic factors influencing metabolic memory in type 2 diabetes.
    Vasishta S; Umakanth S; Adiga P; Joshi MB
    Vascul Pharmacol; 2022 Feb; 142():106933. PubMed ID: 34763098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammation-Related Epigenetic Modification: The Bridge Between Immune and Metabolism in Type 2 Diabetes.
    Ding Q; Gao Z; Chen K; Zhang Q; Hu S; Zhao L
    Front Immunol; 2022; 13():883410. PubMed ID: 35603204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of DNA methylation in diabetes and obesity.
    Chu DT; Bui NL; Vu Thi H; Nguyen Thi YV
    Prog Mol Biol Transl Sci; 2023; 197():153-170. PubMed ID: 37019591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.